AMGN AMGEN INC Management Changes 8-K Filing 2023 - Appointments Amgen Inc. announces the appointment of David M. Reese as Executive Vice President and Chief Technology Officer, and James Bradner as Executive Vice President, Research and Development, and Chief Scientific Officer.Get access to all SEC 8-K filings of the AMGEN INC